---
title: "Definium Therapeutics climbs 5% to 52-week high after employee stock grant"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292222203.md"
description: "Definium Therapeutics (DFTX.US) gained 5% to 52-week high at $47.68 after granting stock options to 8 new employees."
datetime: "2026-07-09T16:01:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292222203.md)
  - [en](https://longbridge.com/en/news/292222203.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292222203.md)
generator: "portal-rs"
---

# Definium Therapeutics climbs 5% to 52-week high after employee stock grant

Definium Therapeutics(DFTX.US) 盘中涨超 5%，现报 47.68 美元，股价创 52 周新高，日内最高触及 47.73 美元。

消息面上，公司 7 月 6 日宣布向 8 名新入职非高管员工授予**169,740**份普通股期权，期权按纳斯达克规则获批，归属期为**4**年。

### Related Stocks

- [DFTX.US](https://longbridge.com/en/quote/DFTX.US.md)

## Related News & Research

- [What Do Definium Therapeutics (DFTX) Phase 3 GAD Results Mean For DT120?](https://longbridge.com/en/news/295821556.md)
- [Definium Therapeutics (DFTX) Receives a Buy from Wells Fargo](https://longbridge.com/en/news/295787298.md)
- [Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'](https://longbridge.com/en/news/295680444.md)
- [Definium says LSD-based pill reduces anxiety in late-stage study](https://longbridge.com/en/news/295653550.md)
- [Is Definium Therapeutics (DFTX) Expensive As New GAD Study Sharpens Its Late Stage Case?](https://longbridge.com/en/news/293649367.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**